News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
247 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17909)
Month
January (2961)
February (3165)
March (3318)
April (3244)
May (4160)
June (3267)
July (3145)
August (3370)
September (3134)
October (4161)
November (3326)
December (2436)
Day
1 (131)
4 (247)
5 (175)
6 (176)
7 (195)
8 (123)
11 (157)
12 (176)
13 (142)
14 (165)
15 (118)
18 (159)
19 (164)
20 (139)
21 (160)
22 (101)
25 (172)
26 (171)
27 (125)
28 (153)
29 (116)
30 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
4
5
6
7
8
11
12
13
14
15
18
19
20
21
22
25
26
27
28
29
30
Drug Development
Micromet Final Data from a Phase 2 Trial Presented at American Society of Clinical Oncology Specifies Dose-dependent Activity of Adecatumumab (MT201)
June 4, 2007
·
7 min read
Business
IPS Announces Formation of Technical Advisory Board
June 4, 2007
·
1 min read
Drug Development
GlaxoSmithKline Reports Positive New Data at American Society of Clinical Oncology
June 4, 2007
·
10 min read
Drug Development
IDM Pharma, Inc. Presents Interim Phase II Data From EP-2101 Lung Cancer Vaccine Clinical Trial
June 4, 2007
·
7 min read
Drug Development
Can-Fite BioPharma Successfully Completes Long-Term Toxicology Studies With CF101 in Full GLP Compliance With FDA
June 4, 2007
·
1 min read
Drug Development
Sanofi-Aventis (France) and Regeneron Pharmaceuticals, Inc. Results of VEGF Trap (Aflibercept) Highlighted at American Society of Clinical Oncology 2007 Annual Meeting
June 4, 2007
·
11 min read
Pharm Country
Nutrition21 Landmark Study Shows Diachrome(R) Significantly Improves Blood Sugar Control in People with Type 2 Diabetes
June 4, 2007
·
1 min read
Drug Development
OncoGenex Technologies Inc. and Isis Pharmaceuticals, Inc. Study Presented at American Society of Clinical Oncology Shows Encouraging One-Year and Overall Survival Results for Phase I/II Trial of OGX-011 in Non-Small Cell Lung Cancer
June 4, 2007
·
6 min read
Business
EKR Therapeutics Expands Its Management Team in Support of Growth Momentum
June 4, 2007
·
1 min read
Drug Development
Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society of Nuclear Medicine 2007 Annual Meeting
June 4, 2007
·
1 min read
Previous
21 of 25
Next
